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Persons who survive a spontaneous SAH often expe-rience a poor psychosocial outcome even after good neurological recovery. Their HRQOL is often found 
to be impaired in comparison with both general popula-
tion norms8,11,14,15,17,19,35,37 and other patient groups.22,24,30 
How patients can be supported to achieve a better psy-
chosocial outcome remains unclear, but a range of factors 
might be important, including the support and care that 
they receive, not only from health professionals but also 
from their SOs—that is, their spouses, partners, and close 
relatives.39
However, many SOs experience symptoms of psy-
chological distress including anxiety,14,31 depression,5,32 
stress,2,12,13,23,30,32 and sleep dysfunction,23 which may af-
fect their ability to care for the patient. More specifically, 
despite a further hemorrhage being rare,7,25,36,40,43 many 
SOs of patients with SAH report feelings of anxiety and 
uneasiness over their loved one suffering a recurrence.14,38 
These elevated fears could further hamper the patient’s 
psychosocial recovery if SOs react by overly restricting 
the patient’s everyday activities. There is some evidence 
suggesting that this might occur, with research by Hop et 
al.14 finding that 4 months following the SAH, some SOs 
remained reluctant to leave the patient alone in case an-
other hemorrhage occurred. Of course, the patient’s own 
fears of recurrence1,3,4,16,20,21,24,38 might produce similar—
or even bigger—restrictions. Seemingly as a consequence 
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13 months postictus for their fears of recurrence and for health-related quality of life on the 8 domains of the 36-Item 
Short Form Health Survey.
Results. The SOs were found to be significantly more fearful of SAH recurrence than the patients. The SO’s fears 
also explained unique variance in the patient’s recovery on 4 of the 36-Item Short Form Health Survey domains over 
and above the patient’s own fears, demographic and/or neurological variables, and the patient’s history of psychiatric 
or neurological problems. The domains affected reflected activity-based and functional aspects of the patient’s quality 
of life as opposed to more general characteristics of their emotional well-being or physical health state.
Conclusions. The patient’s recovery may be compromised if their spouse, close family, and/or friends are exces-
sively fearful about their suffering a recurrence. Perhaps the SO’s fears cause them to be overprotective of the patient 
and to restrict their day-to-day activities. Attention must therefore be given to the experience of having a loved one 
suffer from an SAH, and alleviating the caregiver’s fears could help to promote a better outcome for the patient.
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of their own fears, patients with SAH can place restric-
tions on their day-to-day lives, such as not participating 
in certain activities like driving, lifting, using machinery, 
sexual intercourse, and physical exertion.1,3,14,21,41
It is unknown, however, whether the fears of either the 
patients or their SOs contribute in any way to the pa tient’s 
psychosocial recovery—and if they do, which domains of 
quality of life are most affected. This paper addresses this 
gap in the literature by presenting data that show the rela-
tive contributions of both the patient’s and the SO’s fears 
of recurrence on patient psychosocial recovery measured 
at approximately 13 months postictus. The effects on dif-
ferent domains of quality of life were compared using the 
SF-36 measure of HRQOL,42 which provides an 8-domain 
profile of functional health and well-being in the follow-
ing domains: 1) physical functioning; 2) role limitations 
due to physical problems; 3) bodily pain; 4) general health 
perceptions; 5) vitality/energy; 6) social functioning; 7) 
role limitations due to emotional problems; and 8) mental 
health (Fig. 1).
Our first aim was to establish whether the patients 
and SOs shared the same fears of SAH recurrence. Given 
that the patient/SO pair have experienced the same trau-
matic event, we might expect that their fears are related—
that is, patients who are most fearful of SAH recurrence 
are paired with SOs who are also most fearful. However, 
prior SAH studies have shown that SOs can have higher 
levels of emotional distress than the patient.5,14,32 There-
fore, we tested whether the SOs were more or less fear-
ful of SAH recurrence than the patients themselves. We 
also compared their fears of SAH recurrence with their 
fear levels regarding the possibility of the patient’s devel-
oping 3 other health problems (PD, heart attack caused 
by coronary artery disease, and lung cancer). We were 
interested in whether any differences found between the 
SO’s and the patient’s fear levels were specific to SAH 
recurrence or whether they generalized to other types of 
health problems.
Our second aim was to use regression modeling to 
test whether the SO’s fears could make a unique contri-
bution to the patient’s psychosocial recovery over and 
above the patient’s own fears of recurrence. The analysis 
Fig. 1. Schematic structure of the domains in the SF-36 questionnaire used in this study.
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also controlled for the patient’s age, sex, initial clinical 
grade of SAH, and premorbid history of psychiatric or 
neurological problems. We were particularly interested in 
exploring which, if any, of the 8 SF-36 domains of the 
HRQOL were most affected by the patient’s own and the 
SO’s fears of recurrence.
Methods
Study Participants
A group consisting of 69 patients who had suffered 
a spontaneous SAH and their SOs was enrolled in this 
prospective study and was assessed an average of 13.2 
months postictus (SD 1.43 months). All patients were 
noninstitutionalized first-time sufferers of SAH who had 
been admitted to Newcastle General Hospital or James 
Cook University Hospital, Middlesbrough, between May 
2005 and August 2006 and were recruited as part of a 
wider study on outcome after SAH.26,27 The diagnosis was 
confirmed by CT scan or, if scanning was negative, by 
the presence of blood or blood products in the CSF. An-
eurysms were demonstrated by CT, MR, or catheter angi-
ography. The SOs were approached through the patients, 
who passed an invitation to the SO if they wished him or 
her to participate. An SO was defined as the person the 
patient felt closest to and who was the most involved in 
providing informal support after the illness.
Multicenter approval was awarded by the Central 
Man chester Research Ethics Committee. Informed con-
sent was obtained from all participants.
Measures Used in the Study
Fear Ratings. Each member of the patient/SO pair 
independently rated how much they feared the patient 
suffering from 4 different health problems in the future: 
another SAH, lung cancer, PD, and a heart attack caused 
by coronary artery disease. A 5-point rating scale devel-
oped for this study (0 = no fear, 4 = extreme fear) was 
used. We asked the patient/SO pairs to rate their fears 
of the patient suffering from 3 health problems unrelated 
to SAH to establish whether any differences or similari-
ties that we might observe between their fear levels were 
unique to the SAH event.
Quality of Life. The SF-3642 was used to assess the 
patient’s HRQOL across 8 domains: 1) physical function-
ing; 2) role limitations due to physical problems; 3) bodily 
pain; 4) general health perceptions; 5) vitality/energy; 6) 
social functioning; 7) role limitations due to emotional 
problems; and 8) mental health.
Data Analysis
Pearson correlation coefficients were used to exam-
ine the degree to which the fear ratings of the patient/SO 
pairs were related, and mean differences between their 
ratings were tested for significance by using paired t-tests. 
These analyses were conducted for each of the fear rat-
ings (that is, SAH, heart attack, lung cancer, and PD).
Multiple regression analysis was used to determine 
the extent to which the fears of SAH recurrence of each 
member of the patient/SO pair uniquely contributed to the 
psychosocial recovery of the patient on each of the 8 SF-
36 HRQOL domains. The regression models controlled 
for the patient’s age, sex, the initial clinical grade of the 
condition according to the WFNS scale,9 and whether the 
patient reported a history of a diagnosed psychiatric ill-
ness or neurological condition prior to the hemorrhage. 
Although the sample size was quite small, the case/vari-
able ratio of 69:7 was close to the commonly reported rule 
of thumb that specifies 10 cases per variable to produce 
a reliable regression model.10 Moreover, an a priori cal-
culation performed using G*Power 3.1.5 (www.psycho.
uni-duesseldorf.de/abteilungen/aap/gpower3) confirmed 
that the study was powered sufficiently to demonstrate 
medium effect sizes (that is, Cohen f2 = 0.117)6 for signifi-
cance tests of the increase in variance that each predictor 
could add to the model.
Results
Patient/SO Pair Sample
The demographic characteristics of the 69 patient/
SO pairs are shown in Table 1. As shown, the SOs were 
slightly more likely to be female and, on average, were 
just over 2 years younger than the patients, but the differ-
ence in age was not statistically significant (t(68) = 1.87, p 
= 0.066). A large majority of patients were initially grad-
ed as either WFNS Grade I or II (81.1%) and therefore 
presented with high Glasgow Coma Scale scores (≥ 13) 
and without focal neurological deficits.
Patient Versus SO Fear Ratings
Table 2 shows the correlations between the patient’s 
fears and those of the SO. Fears of SAH recurrence were 
unrelated, with no evidence that the patients who were 
most fearful of SAH recurrence were paired with the SOs 
who were also most fearful. Although fear of the patient’s 
developing lung cancer were more likely to be shared (the 
TABLE 1: Characteristics of the 69 patient/SO pairs
Characteristic Patients w/ SAH SOs
age in yrs
 mean ± SD 53.7 ± 10.4 51.0 ± 14.3
 range 28–80 19–79
sex
 % female 53.6 60.9
 % both male  1.4
 % both female 15.9
 % mixed 82.6
% w/ WFNS grade
 I 71.0
 II 10.1
 III  7.2
 IV 11.6
history of psychiatric illness 28.9
history of neurological condition 30.4
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correlation shown in Table 2 is statistically significant), 
fears of PD and heart attack were not correlated.
The mean values of the fear ratings ± SD are also 
shown in Table 2. The first finding to note is that there 
was no average tendency for patients or SOs to be more 
or less fearful of the patient suffering from lung cancer, 
PD, or a heart attack. In stark contrast, however, the SOs 
were significantly more fearful than the patients were 
themselves of SAH recurrence. Further examination of 
the distribution of responses showed that this difference 
was largely produced by a lower proportion of “no fear” 
ratings in the SOs rather than a higher proportion of “ex-
treme fear” ratings: “no fear” ratings were given by 34.3% 
of patients and 17.4% of SOs, whereas at the other end of 
the scale “extreme fear” ratings were given by 18.8% of 
patients and 21.7% of SOs.
Role of Patient/SO Fears in Explaining HRQOL
The estimated regression coefficients are reported in 
Table 3 for each of the 8 SF-36 domains of quality of 
life. The combined effects of the predictors explained be-
tween 18% (bodily pain) and 28% (social functioning and 
role limitations-emotional) of the variance in HRQOL. 
However, the contributions of the individual predictors 
varied across the 8 domains. Neurological history ex-
plained the largest amount of variance in general health 
perceptions (DR2 = 11.8%) and role limitations-physical 
(DR2 = 13.8%). Psychiatric history explained up to 10% of 
the variance in social functioning (DR2 = 9.9%), role lim-
itations-emotional (DR2 = 7.1%), and mental health (DR2 
= 5.6%). It is notable that the fears of the SOs rather than 
the fears of the patients themselves explained significant 
variance in 4 domains: social functioning (DR2 = 8.1%); 
general health perceptions (DR2 = 7.7%); physical func-
tioning (DR2 = 7.4%); and role limitations-emotional (DR2 
= 5.1%). In contrast, the only coefficient close to signifi-
cance for the patient’s own fears was for role limitations-
emotional (DR2 = 4.1%, p = 0.074).
Discussion
This paper has demonstrated that patients with SAH 
and their SOs do not share the same fears of recurrence. 
Most notably, the SOs were significantly more fearful 
than the patients, although the patients and SOs were 
TABLE 2: Correlations and differences between patient/SO pairs’ 
fears of the patient suffering from 4 different health problems in 
the future*
Condition
Pearson  
Correlation Patients SOs
Paired  
t-Test
SAH recurrence 0.077 1.48 ± 1.49 2.04 ± 1.39 −2.37†
lung cancer 0.358‡ 1.24 ± 1.17 1.36 ± 1.25 −0.72
PD −0.024 0.88 ± 1.11 0.88 ± 1.08 0.00
heart attack 0.097 1.70 ± 1.15 1.56 ± 0.99 0.77
* Fear ratings for patients and SOs are expressed as the mean ± SD. 
† p < 0.05. 
‡ p < 0.01.
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equally fearful of the patient suffering from a heart at-
tack, lung cancer, and PD. If this finding can be repli-
cated in further samples of SAH patients and their SOs, 
we would need to look beyond stable dispositional factors 
such as age, sex, personality, and dispositional optimism 
to explain the difference.34 Whatever is causing the dif-
ference, the lack of correspondence between the patient’s 
and SO’s fears of SAH recurrence turns out to be a result 
of great significance when we examine the findings from 
the regression analyses.
Specifically, only the SO’s fears explained more than 
5% of variance in any of the domains of the patient’s 
HRQOL. The patient’s own fears explained no significant 
variance, and the contribution was typically negligible 
(that is, less than 1% of variance). The only domain where 
the patient’s own fear rating was close to the threshold 
for significance was in role limitations-emotional, where 
approximately 4% of the variance was explained. The 
patient’s fears of recurrence appeared to interfere a little 
with their work and daily activities. However, the SO’s 
fears of recurrence interfered more—not only with the 
patient’s work and daily activities (role limitations-emo-
tional), but also with their social activities (social func-
tioning), ability to undertake moderate or vigorous physi-
cal activities (physical functioning), and ratings of health 
in general (general health perceptions). The SO’s fears 
made no significant contribution, however, to the patient’s 
level of anxiety or depression (mental health), how worn 
out (vitality/energy) or in pain they were (bodily pain), or 
the effects that the patient’s health was having on their 
work and daily activities (role limitations-physical).
Although further research is needed to explore why 
the SO’s fears impact the patient’s recovery, this pattern 
of findings suggests that the effect might stem from a 
desire to protect the patient from coming to any harm. 
Although SOs may be acting with the best of intentions, 
a desire to protect the patient could mean that they are 
inadvertently placing restrictions on what the patient does 
both physically and socially. Perhaps SOs help them a bit 
too much with everyday physical tasks and limit social 
activities, thereby slowing down physical rehabilitation, 
ability to return to work, and participation in daily and 
social activities.
In accordance with a previous meta-analysis we con-
ducted,28 the present study also found that demographic 
and neurological information on the patient explained no 
significant variance in any of the domains of the patient’s 
HRQOL: the patient’s sex contributed less than 1%, age 
less than 4%, and WFNS score less than 5%. Significant 
variance was explained, however, by information on the 
premorbid mental and neurological state. A history of 
psychiatric illness explained up to 10% of the variance in 
social functioning, role limitations-emotional, and men-
tal health; a history of neurological conditions explained 
over 11% of the variance in general health perceptions 
and role limitations-physical. These findings partially 
support previous research showing that prior physical and 
mental health problems accounted for between 12% and 
15% of variance in mood disturbance, but no significant 
variance in functional outcomes.29 Our findings show an 
equivalent effect of psychiatric history on mental health, 
but no effect of neurological history. Another difference 
was the impact on functional outcomes: psychiatric his-
tory predicted social functioning (how much physical 
health or emotional problems have interfered with nor-
mal social activities) and role limitations-emotional (how 
much emotional problems have interfered with work and 
daily activities), whereas neurological history predicted 
role limitations-physical (how much physical health prob-
lems have interfered with work activities) and general 
health perceptions (rating of health in general).
These findings raise questions about whether a pre-
morbid history of psychiatric or neurological problems 
compromises the recovery of patients with SAH and 
whether they therefore need additional support. To answer 
these questions we would need to know of course what 
their quality of life was like before the SAH to rule out 
the possibility that the deficits shown here simply reflect 
their premorbid health state. Without a premorbid mea-
sure we can only speculate whether the size of the defi-
cits found are commensurate with how we might expect a 
psychiatric or neurological problem to impact someone’s 
quality of life. This type of investigation would require 
a large sample of patients with SAH for whom detailed 
profiles were obtained about their prior medical history 
to allow comparisons to be made between their HRQOL 
scores and the norms obtained from equivalent patient 
groups. This type of analysis is outside the scope of the 
present study but warrants future investigation.
Although it is plausible to conclude that the reduced 
functioning in patients whose SOs are fearful of recur-
rence is the result of the SO’s emotions, motivations, and/
or actions (possibly since diagnosis), the current study has 
a number of limitations that should be noted. First, the 
sample size was relatively small, and until they are repli-
cated in other samples we cannot rule out the possibility 
that the results were unique, for some unexplained reason, 
to the cohort studied. The cross-sectional design used in 
this study also means that we need to be cautious in of-
fering a causal interpretation. Although cross-sectional 
analyses are not unusual in research that has examined 
the interdependencies between a patient’s quality of life 
and their caregiver’s attitudes or emotions,18,33 further re-
search in which a longitudinal design is used would be 
desirable. The causal interpretation would also be stron-
ger if a randomized controlled trial were conducted to 
test whether an intervention designed to address, reduce, 
and manage the SO’s fears can bring about improved pa-
tient quality of life over time.
Conclusions
The findings of this study suggest a need to offer 
greater support and assistance to the SOs of patients with 
SAH. On average, their fears of SAH recurrence were 
inflated compared with those of the patients themselves, 
and importantly, these fears were associated with com-
promised functioning in certain domains of the patient’s 
quality of life. It is therefore important not to neglect the 
emotions and anxieties of the SO as well as the patient 
early on in the treatment and rehabilitation process. If the 
source of their fears can be identified and addressed, the 
functioning of patients may potentially be improved.
J. Covey, A. J. Noble, and T. Schenk
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